Merck & Co. logo

Merck & Co. MRK

$ 116.89 -0.65%

Quarterly report 2025-Q3
added 11-05-2025

report update icon

Country

usaUSA

IPO year

-

Industry

Biotechnology

Stock Exchange

NYSESPB

Shares

2.53 B

Market Cap[1]

$ 296 B

EBITDA (LTM)

$ 2.86 B

P/E (LTM)

15.97

P/S (LTM)

4.55

EPS (LTM)

7.34

Merck & Co., Inc. is a global pharmaceutical company that specializes in the development, manufacturing, and distribution of innovative medicines, vaccines, and animal health products. Founded in 1891, Merck has grown to become one of the largest pharmaceutical companies in the world, with operations in over 140 countries.

The company's mission is to improve the health and well-being of people and animals around the world. Merck is committed to discovering new treatments and cures for some of the most challenging diseases, including cancer, Alzheimer's disease, and HIV/AIDS. The company has a strong pipeline of products in development, with a focus on immunotherapy and oncology.

Merck is also a leader in the development and distribution of vaccines. The company has played a key role in the fight against infectious diseases such as measles, mumps, rubella, and HPV. Merck's vaccines have saved countless lives around the world and continue to be an important tool in preventing disease outbreaks.

In addition to its pharmaceutical and vaccine business, Merck also has a thriving animal health division. The company develops and manufactures products for livestock, pets, and wildlife. Merck's animal health products are used to prevent and treat diseases in animals, improving their health and welfare.

Merck is committed to operating responsibly and sustainably. The company has set ambitious goals to reduce its environmental impact, improve the health and safety of its employees, and support the communities where it operates. Merck has been recognized for its sustainability efforts, including being named to the Dow Jones Sustainability Index for the past 16 years.

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Akebia Therapeutics Akebia Therapeutics
AKBA
$ 1.48 -1.67 % $ 277 M Nasdaq Global Market usaUSA
Acer Therapeutics Acer Therapeutics
ACER
- 2.71 % $ 14 M Nasdaq Capital Market usaUSA
MorphoSys AG MorphoSys AG
MOR
- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc
ADAP
- -15.15 % $ 60.3 M Nasdaq Global Select Market britainBritain
Adverum Biotechnologies Adverum Biotechnologies
ADVM
- - $ 86.2 M Nasdaq Global Market usaUSA
Amarin Corporation plc Amarin Corporation plc
AMRN
$ 14.7 -0.34 % $ 5.99 B Nasdaq Global Market irlandaIrlanda
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
$ 79.9 -0.55 % $ 1.54 B Nasdaq Global Market,SPB usaUSA
Acasti Pharma Acasti Pharma
ACST
- 4.01 % $ 150 M Nasdaq Capital Market canadaCanada
Aptorum Group Limited Aptorum Group Limited
APM
$ 0.88 5.24 % $ 4.8 M Nasdaq Global Select Market chinaChina
I-Mab I-Mab
IMAB
- - $ 866 M Nasdaq Global Select Market chinaChina
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
- - $ 26.5 M Nasdaq Global Select Market usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
- - $ 40.3 B Nasdaq Global Select Market usaUSA
Adagene Adagene
ADAG
$ 2.66 -0.37 % $ 150 M Nasdaq Global Market chinaChina
Biophytis SA Biophytis SA
BPTS
- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
AlloVir AlloVir
ALVR
- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
- -11.43 % $ 502 K NYSE American usaUSA
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
$ 3.5 -2.1 % $ 8.42 B Nasdaq Capital Market australiaAustralia
Applied Molecular Transport Applied Molecular Transport
AMTI
- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
ARCA biopharma ARCA biopharma
ABIO
- 1052.0 % $ 415 M Nasdaq Capital Market usaUSA
BioNTech SE BioNTech SE
BNTX
$ 110.96 0.56 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Cabaletta Bio Cabaletta Bio
CABA
$ 2.48 1.64 % $ 2.9 M Nasdaq Global Select Market usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
- -24.86 % $ 820 K Nasdaq Global Select Market usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
$ 1.75 2.05 % $ 157 M Nasdaq Global Market,SPB israelIsrael
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
- - $ 1.01 B Nasdaq Global Market usaUSA
Aptose Biosciences Aptose Biosciences
APTO
- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
Albireo Pharma Albireo Pharma
ALBO
- -0.23 % $ 916 M Nasdaq Capital Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
- - - MOEX russiaRussia
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
$ 220.07 -0.88 % $ 5 B Nasdaq Global Select Market danmarkDanmark
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
- 3.16 % $ 1.9 M Nasdaq Global Select Market usaUSA
Aptinyx Aptinyx
APTX
- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
Aravive Aravive
ARAV
- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Arena Pharmaceuticals Arena Pharmaceuticals
ARNA
- -6.81 % $ 3.04 B Nasdaq Global Select Market,SPB usaUSA
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
CORT
$ 41.12 -0.46 % $ 4.24 B Nasdaq Capital Market,SPB usaUSA
Burford Capital Limited Burford Capital Limited
BUR
$ 9.23 2.9 % $ 1.44 B NYSE britainBritain
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
- 17.91 % $ 11.1 M Nasdaq Capital Market usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
$ 24.29 -0.67 % $ 2.88 B Nasdaq Capital Market usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
- -10.17 % $ 12.2 K NYSE American usaUSA
Athira Pharma Athira Pharma
ATHA
- - $ 269 M Nasdaq Global Select Market usaUSA
Athersys Athersys
ATHX
- 3.77 % $ 22.4 M Nasdaq Capital Market usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
$ 49.94 0.48 % $ 4.21 B Nasdaq Global Market,SPB schweizSchweiz
Champions Oncology Champions Oncology
CSBR
$ 6.54 -0.15 % $ 89.3 M Nasdaq Capital Market usaUSA
Akouos Akouos
AKUS
- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
$ 4.45 5.33 % $ 9.68 B NYSE American israelIsrael
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
$ 1.46 - $ 373 M Nasdaq Global Select Market britainBritain
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
$ 14.48 -0.28 % $ 4.47 B NYSE usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.